ArticleBMC complementary medicine and therapies2026
Trachystemon orientalis (L.) G. Don aqueous extract induces cell cycle arrest and apoptosis in MCF-7 breast cancer cells via multi-pathway modulation.
Article in BMC complementary medicine and therapies, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
BACKGROUND/
objectivesTrachystemon orientalis (TO) is native to Bulgaria, the western Caucasus, and Turkey. It possesses antimicrobial, antifungal, and antidiabetic properties. Due to their efficacy and lower toxicity, the search for natural compounds with anticancer potential, especially for breast cancer, has increased. This study evaluated the cytotoxic effects on breast cancer cells.
methodsMCF-7 breast cancer cells and CCD-1072Sk normal fibroblast cells were treated with TO extracts prepared using water, methanol, ethanol, and dimethyl sulfoxide (DMSO). Cytotoxicity was assessed in a dose- and time-dependent manner, and IC₅₀ values were calculated. The most potent extract, water, was analyzed for its effects on cancer-related pathways via RT-qPCR, gene enrichment, and gene-metabolite association analyses. Flow cytometry was used to assess cell cycle distribution and apoptosis, and fluorescence staining was used to evaluate nuclear, cytoskeletal, and mitochondrial morphology.
resultsTO exhibited dose-dependent cytotoxicity in MCF-7 cells, with IC₅₀ values ranging from 28.88 ± 1.91 ng/µL (water extract) to 185.30 ± 6.60 ng/µL (ethanol extract), demonstrating lower toxicity in normal cells. KEGG pathway enrichment analysis showed that the water extract was associated with the modulation of several cancer-related signaling pathways, including p53, HIF-1, TNF, PI3K–Akt, and MAPK pathways, which induced S-phase arrest and increased apoptosis by 11% as confirmed by morphological changes.
conclusionsTaken together, these findings indicate that TO has cytotoxic and apoptosis-inducing effects on breast cancer cells through the regulation of multiple signaling pathways and is a potential candidate for further validation in breast cancer research.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.